Product Information
COUGH-COLD TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1112 per EA under NDC 00904663444. Its NADAC has been published 472 times since Sep 20, 2017.
Strength
4; 30 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904663444
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/31/2017
Pharmacological Classes
Price Statistics
The NADAC for COUGH-COLD TABLET has been published 472 times since Sep 20, 2017, and over the history we have for it it has risen 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1112 per EA |
|---|---|
| All-time high | $0.1514 (Jan 15, 2020) |
| All-time low | $0.0817 (Nov 23, 2022) |
| 52-week high | $0.1114 |
| 52-week low | $0.0954 |
| Median price | $0.1079 |
| Average price | $0.1085 |
| Largest weekly change | +35.8% (Dec 18, 2019) |
| Weeks tracked | 472 |
| Tracking since | Sep 20, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorpheniramine maleate, Dextromethorphan HBr market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COUGH-COLD TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COUGH-COLD TABLET, manufactured by Major Pharmaceuticals, is $0.1112 per EA (NDC 00904663444), effective Sep 30, 2026.
How has the price of COUGH-COLD TABLET changed over time?
Over the history we have for it, the NADAC for COUGH-COLD TABLET has risen 24.5%. It has been tracked across 472 weekly CMS publications since Sep 20, 2017.
What are the highest and lowest recorded NADAC prices for COUGH-COLD TABLET?
Since Sep 20, 2017, the NADAC for COUGH-COLD TABLET has ranged from a low of $0.0817 (Nov 23, 2022) to a high of $0.1514 (Jan 15, 2020), with a median of $0.1079 per EA.
Are there cheaper alternatives to COUGH-COLD TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as COUGH-COLD TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures COUGH-COLD TABLET?
COUGH-COLD TABLET (NDC 00904663444) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.